Total Payments
$3,402
2022 Payments
$101.02
Companies
29
Transactions
72
Medicare Patients
2,086
Medicare Billing
$217,695
Payment Breakdown by Category
Food & Beverage$2,852 (83.8%)
Education$549.89 (16.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,852 | 63 | 83.8% |
| Education | $549.89 | 9 | 16.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $524.38 | 7 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $436.02 | 9 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $320.90 | 6 | $0 (2020) |
| Incyte Corporation | $258.00 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $236.69 | 6 | $0 (2019) |
| Genentech USA, Inc. | $173.82 | 7 | $0 (2022) |
| Clovis Oncology, Inc. | $154.31 | 2 | $0 (2019) |
| Millennium Pharmaceuticals, Inc. | $142.62 | 2 | $0 (2017) |
| PFIZER INC. | $127.94 | 2 | $0 (2020) |
| Seagen Inc. | $123.24 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $101.02 | 7 | Daiichi Sankyo Inc. ($27.67) |
| 2021 | $153.19 | 3 | Seagen Inc. ($99.95) |
| 2020 | $97.09 | 5 | E.R. Squibb & Sons, L.L.C. ($37.51) |
| 2019 | $811.30 | 13 | Celgene Corporation ($250.00) |
| 2018 | $665.44 | 13 | Novartis Pharmaceuticals Corporation ($148.80) |
| 2017 | $1,574 | 31 | Novartis Pharmaceuticals Corporation ($287.22) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/20/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2022 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Oncology | ||||||
| 05/26/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Oncology | ||||||
| 05/11/2022 | Genentech USA, Inc. | Alecensa (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: BioOncology | ||||||
| 05/11/2022 | Genentech USA, Inc. | Alecensa (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: BioOncology | ||||||
| 05/11/2022 | Genentech USA, Inc. | Alecensa (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $2.48 | General |
| Category: BioOncology | ||||||
| 02/17/2022 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $20.78 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 10/20/2021 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $15.31 | General |
| 07/20/2021 | Lilly USA, LLC | RETEVMO (Drug) | Food and Beverage | In-kind items and services | $37.93 | General |
| Category: Oncology | ||||||
| 04/15/2021 | Seagen Inc. | — | Education | In-kind items and services | $99.95 | General |
| 10/22/2020 | Seagen Inc. | TUKYSA (Drug) | Education | In-kind items and services | $23.29 | General |
| Category: Oncology | ||||||
| 08/14/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $19.44 | General |
| Category: Oncology | ||||||
| 08/13/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $18.07 | General |
| Category: Oncology | ||||||
| 04/13/2020 | Lilly USA, LLC | ERBITUX (Drug), CYRAMZA | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 02/18/2020 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2019 | Fortovia Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.78 | General |
| 10/24/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $61.31 | General |
| Category: Oncology | ||||||
| 10/03/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $77.15 | General |
| Category: Oncology | ||||||
| 09/12/2019 | EISAI INC. | Halaven (Drug) | Food and Beverage | Cash or cash equivalent | $65.47 | General |
| Category: Oncology | ||||||
| 09/06/2019 | Janssen Biotech, Inc. | Balversa (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: Oncology | ||||||
| 08/22/2019 | Lilly USA, LLC | ERBITUX (Drug), CYRAMZA | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Oncology | ||||||
| 06/19/2019 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 06/11/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Hematology/Oncology | ||||||
| 06/11/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 05/23/2019 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla, TECENTRIQ | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: BioOncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 481 | 581 | $170,558 | $48,407 |
| 2022 | 4 | 444 | 626 | $131,766 | $43,194 |
| 2021 | 8 | 557 | 1,016 | $183,374 | $70,261 |
| 2020 | 9 | 604 | 939 | $164,053 | $55,833 |
Total Patients
2,086
Total Services
3,162
Medicare Billing
$217,695
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 256 | 348 | $87,975 | $25,521 | 29.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 104 | 104 | $50,232 | $14,136 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 58 | 61 | $20,575 | $5,643 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 63 | 68 | $11,776 | $3,107 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 130 | 243 | $48,600 | $16,104 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 150 | 213 | $29,820 | $8,628 | 28.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 54 | 54 | $18,078 | $6,469 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 52 | 53 | $12,750 | $4,100 | 32.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 27 | 27 | $12,546 | $4,071 | 32.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 36 | $9,972 | $3,822 | 38.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 213 | 517 | $100,040 | $38,920 | 38.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 187 | 310 | $41,915 | $14,379 | 34.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 49 | 67 | $17,579 | $7,307 | 41.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $6,156 | $2,591 | 42.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 24 | 25 | $4,880 | $1,846 | 37.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $3,762 | $1,344 | 35.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 12 | $2,220 | $1,240 | 55.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $2,446 | $1,157 | 47.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 31 | $2,556 | $745.42 | 29.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 14 | $1,820 | $730.83 | 40.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 214 | 428 | $74,889 | $24,323 | 32.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 75 | 103 | $24,120 | $8,463 | 35.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 168 | 253 | $30,321 | $8,315 | 27.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 42 | 42 | $13,860 | $5,218 | 37.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 15 | $4,911 | $2,425 | 49.4% |
About Dr. Bryan Lee, DO
Dr. Bryan Lee, DO is a Internal Medicine healthcare provider based in Springfield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2012. The National Provider Identifier (NPI) number assigned to this provider is 1790020618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Lee, DO has received a total of $3,402 in payments from pharmaceutical and medical device companies, with $101.02 received in 2022. These payments were reported across 72 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,852).
As a Medicare-enrolled provider, Lee has provided services to 2,086 Medicare beneficiaries, totaling 3,162 services with total Medicare billing of $217,695. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Springfield, MA
- Active Since 12/04/2012
- Last Updated 10/09/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1790020618
Products in Payments
- OPDIVO (Biological) $320.90
- JAKAFI (Drug) $258.00
- Abraxane (Drug) $211.22
- VELCADE (Drug) $186.19
- LYNPARZA (Drug) $179.49
- Rubraca (Drug) $154.31
- KISQALI (Drug) $126.41
- Revlimid (Drug) $125.00
- GAZYVA (Biological) $114.58
- IBRANCE (Drug) $111.65
- SOLIRIS (Drug) $106.55
- Halaven (Drug) $83.66
- Cabometyx (Drug) $70.31
- Lonsurf (Drug) $67.94
- NINLARO (Drug) $65.63
- Venclexta (Drug) $50.04
- Alecensa (Biological) $48.44
- ERBITUX (Drug) $43.50
- RETEVMO (Drug) $37.93
- AFINITOR (Drug) $36.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Springfield
Dr. Steven Gradney, M.d, M.D
Internal Medicine — Payments: $568,658
Internal Medicine $568,658
Dr. James Bonucchi, Do, DO
Internal Medicine — Payments: $304,681
Internal Medicine $304,681
John Flack, Md, Mph, MD, MPH
Internal Medicine — Payments: $125,897
Internal Medicine $125,897
Dr. Sudeshna Banerjee, Md, MD
Internal Medicine — Payments: $62,767
Internal Medicine $62,767
Dr. Paul Madaj, M.d, M.D
Internal Medicine — Payments: $58,030
Internal Medicine $58,030
Dr. Indrajeet Mahata, M.d, M.D
Internal Medicine — Payments: $47,372
Internal Medicine $47,372